CompletedPHASE1, PHASE2NCT01856868

Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)

Studying Becker muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Craig McDonald, MD
Principal Investigator
Craig M McDonald, MD, MD
University of California, Davis
Intervention
(-)-epicatechin(drug)
Enrollment
7 enrolled
Eligibility
18-60 years · MALE
Timeline
20132018

Study locations (1)

Collaborators

Cardero Therapeutics, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01856868 on ClinicalTrials.gov

Other trials for Becker muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Becker muscular dystrophy

← Back to all trials